Kazire Vidicine

Kazire

Vidicine

Kazire Vidicine is a scientifically tested herbal formulation developed by Kazire Health Products Limited. It has successfully passed clinical trials under the study "Safety, Pharmacokinetics, and Preliminary Efficacy of Vidicine for the Treatment of Acute Respiratory Viral Infections, Including SARS-CoV-2 in Uganda." The study, conducted by Makerere Lung Institute under the leadership of Dr. Bruce Kirenga and supervised by the Ministry of Science, Technology, and Innovation (STI-OP),involved 510 participants in health centers in and around Kampala between March 2023 and July 2024.

Findings from both in vivo and in vitro studies confirmed that Vidicine possesses antiviral, antibacterial, and antioxidant properties, making it a promising herbal treatment for acute respiratory viral infections such as COVID-19 and other respiratory conditions. These results support Vidicine’s potential role in managing respiratory infections while boosting immunity and reducing inflammation.